Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma

British Journal of Haematology

Volumn 93, Issue 2, 1996, Pages 398-400

  Kyrtsonis, Maria Christina ^d   Dedoussis, Georges ^b   Zervas, Constantin ^c   Perifanis, Vassilis ^c   Baxevanis, Constantin ^b   Stamatelou, Marina ^a   Maniatis, Alice ^d  

^a Department of Medicine   (Greece)

^b Department of Cytology   (Greece)

^c THEAGENIO CANCER HOSPITAL   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

multiple myeloma; prognosis; soluble interleukin 6 receptor

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; INTERFERON; INTERLEUKIN 6 RECEPTOR; MELPHALAN; PREDNISONE; VINCRISTINE;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029914360     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4721018.x     Document Type: Article

References (12)

1. Cavaillon, J-M. (1995) Interleukine-6 Les Cytokines (ed. by J-M. Cavaillon), pp. 185-196. Masson, Paris.
2. Gaillard, J.P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T. & Klein, B. (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. European Journal of Immunology, 23, 820-824.
3. Greipp, P.R., Gaillard, J.P., Klein, B., Oken, M.N., Kalish, L., Leong, T. & Kyle, R.A. (1994) Independant prognostic value for plasma cell labelling index (PCLI), immunofluorescence microscopy plasma cell percent (IMPCP), beta-2-microglobulin (B2M), soluble interleukin-6 receptor (sIL-6R) and C-reactive protein (CRP) in myeloma trial E9487. Blood, 84, (Suppl. 1), 385a.
4. Heaney, M.L. & Golde, D.W. (1993) Soluble hormone receptors. Blood, 82, 1945-1948.
5. Kishimoto, T. (1989) The biology of IL-6. Blood, 74, 1-10.
6. Kishimoto, T., Akira, S. & Taga, T. (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science, 258, 593-597.
7. Klein, B. & Bataille, R. (1992) Cytokine network in human multiple myeloma. Hematology/Oncology Clinics of North America, 6, 273-284.
8. Klein, B., Harousseau, J.L. & Bataille, R. (1993) Cytokine and cytokine receptors in human multiple myeloma. IV International Workshop on Multiple Myeloma, p. 46.
9. Klein, B., Zhang, X-G., Lu, Z-Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
10. Kyrtsonis, M-C., Dedousis, G.V.Z., Papanastasiou, C., Tsakanikas, S., Baxevanis, C., Stamatelou, M. & Maniatis, A. (1994) Soluble interleukin-6 receptor (sIL-6R) levels in serum of patients with multiple myeloma (MM) at diagnosis and during the course of the disease. Blood, 84, (Suppl. 1), 385a.
11. Ohtani, K., Ninomiya, H., Hasegawa, Y., Kobayashi, T., Kojima, H., Nagasawa, T. & Abe, T. (1995) Clinical significance of elevated soluble interleukin-6 receptor levels in sera of patients with plasma cell dyscrasias. British Journal of Haematology, 91, 116-120.
12. Pulkki, K., Pelliniemi, T-T., Irjala, K., Mattila, K., Rajamaki, A., Tienhaara, A., Laasko, M. & Lahtinen, R. (1994) High levels of soluble interleukin-6 receptor (sIL-6R) and immunoreactive interleukin-6 (IL-6) predict poor prognosis in multiple myeloma (MM). Blood, 84, (Suppl. 1), 385a.